Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lipocine Inc. - Common Stock (NQ:LPCN)

3.190 +0.010 (+0.31%)
Streaming Delayed Price Updated: 3:57 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,061
Open 3.260
Bid (Size) 2.790 (2)
Ask (Size) 3.430 (1)
Prev. Close 3.180
Today's Range 3.175 - 3.362
52wk Range 2.750 - 11.79
Shares Outstanding 5,350,356
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024
LPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Performance

YTD
-34.4%
-34.4%
1 Month
-8.1%
-8.1%
3 Month
-32.0%
-32.0%
6 Month
-44.7%
-44.7%
1 Year
-29.9%
-29.9%

More News

Read More
7 Penny Biotech Stocks to Triple Your Investment
Via InvestorPlace
LPCN Stock Earnings: Lipocine Beats EPS for Q1 2024
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
LPCN Stock Earnings: Lipocine Beats EPS for Q4 2023
Via InvestorPlace
Why Is Lipocine (LPCN) Stock Up 32% Today?
Via InvestorPlace
Recap: Lipocine Q1 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Lipocine Stock Is Moving Higher Today?
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is National Vision (EYE) Stock Down 12% Today?
Via InvestorPlace
Why Is Yellow (YELL) Stock Down 27% Today?
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Groupon Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Around $3M Bet On This Basic Materials Stock? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
Nogin And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is Lipocine Inc. - Common Stock publicly traded?
Yes, Lipocine Inc. - Common Stock is publicly traded.
What exchange does Lipocine Inc. - Common Stock trade on?
Lipocine Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lipocine Inc. - Common Stock?
The ticker symbol for Lipocine Inc. - Common Stock is LPCN on the Nasdaq Stock Market
What is the current price of Lipocine Inc. - Common Stock?
The current price of Lipocine Inc. - Common Stock is 3.190
When was Lipocine Inc. - Common Stock last traded?
The last trade of Lipocine Inc. - Common Stock was at 04/25/25 03:57 PM ET
What is the market capitalization of Lipocine Inc. - Common Stock?
The market capitalization of Lipocine Inc. - Common Stock is 17.07M
How many shares of Lipocine Inc. - Common Stock are outstanding?
Lipocine Inc. - Common Stock has 17M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.